Atlas Trials

Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Clinical trial NCT00854568 · COMPLETED

Trial details

NCT number
NCT00854568
Sponsor
Fudan University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2009-03-01
Primary completion
2012-12-01
Enrollment
398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.